The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Cannabinoid self‐administration in rats: sex differences and the influence of ovarian function
Open accessAbstract
Background and purpose: We recently demonstrated the existence of strain differences in self‐administration of the cannabinoid CB 1 receptor agonist WIN55,212‐2 (WIN) by Long Evans (LE) and Lister Hooded (LH) but not Sprague‐Dawley (SD) male rats. This follow‐up study is aimed at verifying whether sex and ovarian hormones might also be critical factors in the initiation, retention and extinction of WIN self‐administration. Experimental approach: LE, LH and SD male and female rats, the latter either intact or bilaterally ovariectomized (OVX), were trained to self‐administer WIN (12.5 μg kg−1 per infusion) under a FR1 reinforcement schedule, using lever‐pressing. Key results: Data showed that contrary to the findings in SD rats, LE and LH rats developed robust cannabinoid intake, with rates of responding for WIN being constantly higher in intact females than in males (+45 and +42% for LE and LH strains, respectively). In comparison with intact females, OVX females of both strains acquired self‐administration at lower rates, displaying slower acquisition, lower drug intake (−42 and −52% for LE and LH, respectively) and longer extinction. Conclusions and implications: These findings provide the first evidence of significant sex differences in cannabinoid self‐administration, females acquiring stable WIN intake at higher rates and more rapidly than males. Moreover, when compared to intact females, a lower percentage of LE and LH OVX rats acquired and maintained stable drug intake, suggesting that ovarian hormones might represent a critical factor in modulating the reinforcing effect of cannabinoids. British Journal of Pharmacology (2007) 152, 795–804; doi:10.1038/sj.bjp.0707465; published online 24 September 2007
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gender differences in substance use disorders
Brady, K. T., & Randall, C. L. (1999) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70074-5 · Cited by 910 · cited 3×
“By acquiring stable WIN intake at a higher rate over a shorter period of time than corresponding male rats, females appear more susceptible to cannabinoid-induced reward, in line with clinical observations reporting women as more vulnerable than men during the transition periods from opportunity to use and drug abuse…”
BackgroundResultSex differences in the acquisition of intravenously self-administered cocaine and heroin in rats
Lynch, W. J., & Carroll, M. E. (1999) · Psychopharmacology · doi:10.1007/s002130050979 · Cited by 463
de Fonseca, F. R., Cebeira, M., Ramos, J. A., Martín, M., & Fernández-Ruiz, J. J. (1994) · Life Sciences · doi:10.1016/0024-3205(94)00585-0 · Cited by 243
Maier (2005) · doi:10.1016/j.neubiorev.2004.08.001 · Cited by 216 · cited 2×
“A biological basis of sex differences is likely to underlie vulnerability to drug abuse as well as all phases of the addiction cycle, women being seemingly more prone than men to abuse and more responsive to the rewarding effects of addictive drugs (Roth et al., 2004; Lynch, 2006).”
BackgroundInfluentialEmmerson-Hanover, R., Shearer, D. E., Creel, D. J., & Dustman, R. E. (1994) · Electroencephalography and Clinical Neurophysiology/Evoked Potentials Section · doi:10.1016/0168-5597(94)90049-3 · Cited by 109 · cited 1×
“In support of the latter, female and male brains have been shown to differ substantially, differences beginning early during development and continuing throughout the lifespan (Emmerson-Hanover et al., 1994; Becker et al., 2005).”
Background
Cited by
Sex Differences in Animal Models: Focus on Addiction
Becker, J. B., & Koob, G. F. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011163 · Cited by 725
SVIZENSKA, I., DUBOVY, P., & SULCOVA, A. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.05.010 · Cited by 457
Sex-Dependent Effects of Cannabis and Cannabinoids: A Translational Perspective
Cooper, Z. D., & Craft, R. M. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.140 · Cited by 350
Crane, N. A., Schuster, R. M., Fusar-Poli, P., & Gonzalez, R. (2013) · Neuropsychology Review · doi:10.1007/s11065-012-9222-1 · Cited by 309
Anker, J. J., & Carroll, M. E. (2010) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2010_93 · Cited by 299
Craft, R. M., Marusich, J. A., & Wiley, J. L. (2013) · Life Sciences · doi:10.1016/j.lfs.2012.06.009 · Cited by 299
Khan, S. S., Secades-Villa, R., Okuda, M., Wang, S., Pérez-Fuentes, G., Kerridge, B. T., & Blanco, C. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.10.015 · Cited by 293
Estrogenic regulation of limbic cannabinoid receptor binding
Riebe, C. J. N., Hill, M. N., Lee, T. T. Y., Hillard, C. J., & Gorzalka, B. B. (2010) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.02.008 · Cited by 128
al'Absi, M., & Allen, A. M. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.687106 · Cited by 34
Kirschmann, E. K., McCalley, D. M., Edwards, C. M., & Torregrossa, M. M. (2017) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2017.00137 · Cited by 28
Zuo, Y., Iemolo, A., Montilla-Perez, P., Li, H.-R., Yang, X., & Telese, F. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01413-2 · Cited by 25
Metadata
- Authors
- Fattore, L., Spano, M. S., Altea, S., Angius, F., Fadda, P., & Fratta, W.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2007-11
- Volume
- 152
- Issue
- 5
- Pages
- 795-804
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1666625984
- Cited by
- 199
- References
- 5
- FWCI
- 5.68
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.